The posting, in BridgeBio's own words
archived Oct 27, 2026Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
What You'll Do
We are building the operational and compliance backbone of our pricing and contracting function ahead of significant portfolio growth. We support a competitive in-market brand alongside a rare disease pipeline moving into launch, and each product entering the market brings a defined set of statutory obligations, government program enrollments and contract operations requirements — on external deadlines that do not move. This is a new role, created to own that work end to end. You will lead two managers covering commercial contract operations and government programs, hold accountability for government price reporting and state price transparency, own the policies and systems that govern this work, and manage the vendors who deliver calculation and processing. You will be the person who ensures a shifting launch date does not become a missed filing. This is a hands-on leadership role in a lean function. You will build process as well as run it.
Read the full posting ↓
Government pricing and price reporting
Accountability for government price calculations and submissions across federal programs, including AMP, Best Price, Unit Rebate Amount, 340B ceiling price, non-FAMP, and ASP where applicable Class of trade review and assignment, and the eligibility determinations that flow from it Methodology approval, output validation and submission accuracy, with calculation performed by vendors under your oversight Government Price Impact Analysis supporting pricing and contracting decisions State price transparency reporting: new product introduction filings, advance notice requirements and annual reports across applicable jurisdictions Ownership of the reporting compliance calendar
Government programs
Medicaid Drug Rebate Program administration, including state and managed care organization rebate operations, claims research, dispute resolution and reconciliation State Medicaid supplemental rebate agreements Medicare Part D Manufacturer Discount Program, TRICARE, and federal contract administration including FSS and VA/DoD Government program enrollment, NDC addition and contract addenda for each new product
Commercial contract operations
Commercial and Medicare payer contract administration: contract set-up, membership and eligibility management, claims validation, formulary validation, chargeback and administrative fee processing Commercial rebate operations, including verification that contracted performance was delivered before rebates are paid Contract data stewardship and integrity across the contract management system, vendor feeds and financial systems Service to trading partners and payers on contract operations enquiries
Policy, compliance and audit
Ownership of policies and standard operating procedures governing government pricing, price reporting and contract operations Audit readiness and support for internal audits and external customer audits Monitoring the evolving federal and state regulatory landscape, and driving operational readiness for new mandates ahead of effective dates Partnership with Legal and Compliance on reporting obligations and risk assessment